Streptococcus pyogenes empyema as a complication of bilateral SARSCoV- 2 pneumonia (COVID-19)
DOI:
https://doi.org/10.32818/reccmi.a5n2a14Keywords:
SARS-CoV-2, pneumonia, empyema, streptococcus pyogenes.Abstract
Pleural effusion is a common complication of bacterial pneumonia appearing in 20-40% of hospitalized patients. Its appearance in viral pneumonia is less frequent, as well as its evolution to empyema. We present the case of a 63-year-old woman with bilateral pneumonia due to new coronavirus SARS-CoV-2 associated to polymorphonuclear exudate type right pleural effusion with empyema criteria. Streptococcus pyogenes (group A streptococcus) is isolated in pleural fluid. The patient presented a favorable evolution with directed antibiotic
treatment and thoracic drainage tube placement. During hospitalization, she is diagnosed also of a breast neoplasm.
Downloads
Metrics
References
Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006; 3(1): 75-80. doi: https://doi.org/10.1513/pats.200510-113JH.
Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. J Am Coll Radiol. 2020; 17(6): 701-709. doi: https://doi.org/10.1016/j.jacr.2020.03.006.
Asai N, Suematsu H, Sakanashi D, Kato H, Hagihara M, Watanabe H et al. A severe case of Streptococcal pyogenes empyema following influenza A infection. BMC Pulm Med. 2019; 19(1): 25. doi: https://doi.org/10.1186/s12890-019-0787-9.
Actualización no155. Enfermedad por el coronavirus (COVID-19). [Internet]. [citado 4 de julio de 2020]. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_155_COVID-19.pdf
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200(7): e45-e67. doi: https://doi.org/10.1164/rccm.201908-1581ST.
Arabi YM, Al-Omari A, Mandourah Y, Al-Hameed F, Sindi AA, Alraddadi B et al. Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study. Crit Care Med. 2017; 45(10): 1683-1695. doi: https://doi.org/10.1097/CCM.0000000000002621.
Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020: S1684-1182(20)30127-4. Disponible en: http://www.sciencedirect.com/science/article/pii/S1684118220301274. Ultimo acceso: 21.07.2020.
Spring LM, Specht MC, Jimenez RB, Isakoff SJ, Wang GX, Ly A et al. Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic. N Engl J Med. 2020; 383(3): 262-272. doi: https://doi.org/10.1056/NEJMcpc2002422.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Miguel Ángel Verdejo-Gómez, Gonzalo Rivas-Hernández, María Ruíz-Ruigómez, Laura Corbella-Vázquez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
